Charles River Laboratories | CRL - الأصول





الأصول تغيير تاريخ
Agilent USD 13.07B 252M 2026-03
Align Technology USD 6.42B 103.41M 2026-06
Bio-Rad Laboratories USD 10.25B 462M 2026-06
Bruker USD 6.05B 77.8M 2026-06
Cardinal Health USD 57.3B 610M 2026-06
Charles River Laboratories USD 7.53B 198.16M 2026-06
Cigna USD 157.08B 3.82B 2026-06
Concord Medical Services Hldg CNY 6.55B 186.1M 2025-12
CVS Health USD 253.77B 794M 2026-06
Danaher USD 92.37B 8.82B 2026-06
Dentsply International USD 5.2B 25M 2026-06
Elevance Health USD 126.44B 611M 2026-06
Humana USD 57.2B 1.92B 2026-06
Illumina USD 6.65B 91M 2026-06
Incyte USD 7.87B 533.53M 2026-06
Intrexon USD 73.16M 77.88M 2024-06
IQVIA Holdings USD 29.88B 206M 2026-06
Laboratory Of America USD 18.53B 554.8M 2026-06
Lakefront Biotherapeutics EUR 3.35B 21.24M 2026-06
Lonza CHF 18.97B 164M 2025-12
McKesson USD 88.33B 6.01B 2026-06
Merck EUR 52.69B 383M 2026-06
Mettler Toledo International USD 3.67B 2.03M 2026-06
Novartis USD 122.03B 3.5B 2026-06
Pfizer USD 201.13B 6.49B 2026-06
Quest Diagnostics USD 16.94B 266M 2026-06
Revvity USD 12.05B 49.24M 2026-06
Thermo Fisher Scientific USD 113.17B 107M 2026-06
United Therapeutics USD 7.22B 505.9M 2026-06
UnitedHealth USD 309.73B 2.92B 2026-06
Veradigm USD 1.5B 185.94M 2022-12
Waters USD 24.75B 220M 2026-06
West Pharmaceutical Services USD 4.08B 33.4M 2026-06